Mechanisms of biomaterial-induced superoxide release by neutrophils.
Biomaterial-centered infection is an important cause of the failure of prosthetic implants and organs. Because neutrophils mediate host defense against infection, the effect of biomaterials on neutrophil superoxide release and the mechanism of that effect were investigated using three materials commonly employed in surgical practice. The graft materials were expanded polytetrafluorethylene (PTFE), polyurethane and woven dacron. Polystyrene, a commonly used laboratory support vessel, was also studied. Both polystyrene and polyurethane were activating, but serum inhibitable, whereas PTFE was nonactivating, and woven dacron was not activating unless serum was present. The signaling mechanisms used by these materials demonstrated time and material dependency. Pertussis toxin inhibition of G protein-dependent activation had little or no effect on biomaterial induced activation, whereas FMLP-induced activation of the same biomaterial-associated cells was inhibited. Protein kinase C inhibition with staurosporine greatly inhibited polystyrene-induced activation, but had only a partial effect with polyurethane and even less effect with the activation associated with serum-treated woven dacron. These studies demonstrated that biomaterial contact-induced neutrophil activation differed from that described for cells in suspension, and showed that activation mechanisms on one material cannot be extrapolated to mechanisms on other materials.
Kaplan
S S
SS
Department of Pathology, University of Pittsburgh School of Medicine, Pennsylvania.
Basford
R E
RE
Jeong
M H
MH
Simmons
R L
RL
D000470:Alkaloids / Q000494:pharmacology; D001672:Biocompatible Materials / Q000494:pharmacology*; D005549:Foreign-Body Reaction / Q000209:etiology / Q000503:physiopathology*; D019204:GTP-Binding Proteins / Q000037:antagonists & inhibitors; D009240:N-Formylmethionine Leucyl-Phenylalanine / Q000494:pharmacology; D009504:Neutrophils / Q000187:drug effects* / Q000378:metabolism; D037342:Pertussis Toxin; D011093:Polyethylene Terephthalates / Q000494:pharmacology*; D011137:Polystyrenes / Q000494:pharmacology*; D011138:Polytetrafluoroethylene / Q000494:pharmacology*; D011140:Polyurethanes / Q000494:pharmacology*; D011493:Protein Kinase C / Q000037:antagonists & inhibitors; D019311:Staurosporine; D013481:Superoxides / Q000378:metabolism*; D010566:Virulence Factors, Bordetella / Q000494:pharmacology
D000470:Alkaloids; D001672:Biocompatible Materials; D011093:Polyethylene Terephthalates; D011137:Polystyrenes; D011140:Polyurethanes; D010566:Virulence Factors, Bordetella; D013481:Superoxides; D009240:N-Formylmethionine Leucyl-Phenylalanine; D011138:Polytetrafluoroethylene; D037342:Pertussis Toxin; D011493:Protein Kinase C; D019204:GTP-Binding Proteins; D019311:Staurosporine